Nezihi Murat Karabacak, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cell Separation | 4 | 2020 | 1751 | 0.610 |
Why?
|
| Neoplastic Cells, Circulating | 5 | 2020 | 934 | 0.590 |
Why?
|
| Mass Spectrometry | 6 | 2019 | 2204 | 0.550 |
Why?
|
| Microfluidic Analytical Techniques | 2 | 2015 | 828 | 0.370 |
Why?
|
| Fourier Analysis | 2 | 2010 | 447 | 0.350 |
Why?
|
| Proteomics | 1 | 2022 | 3638 | 0.330 |
Why?
|
| Electromagnetic Fields | 1 | 2010 | 298 | 0.310 |
Why?
|
| Microfluidics | 3 | 2020 | 662 | 0.290 |
Why?
|
| Mutant Proteins | 1 | 2008 | 500 | 0.290 |
Why?
|
| Superoxide Dismutase | 4 | 2010 | 596 | 0.230 |
Why?
|
| Molecular Weight | 3 | 2010 | 2255 | 0.220 |
Why?
|
| Prostatic Neoplasms | 1 | 2022 | 11126 | 0.170 |
Why?
|
| Tumor Microenvironment | 2 | 2022 | 3590 | 0.160 |
Why?
|
| Muscle Neoplasms | 1 | 2019 | 139 | 0.150 |
Why?
|
| Stromal Cells | 2 | 2019 | 1355 | 0.140 |
Why?
|
| beta-Globins | 1 | 2017 | 115 | 0.140 |
Why?
|
| Rhabdomyosarcoma | 1 | 2019 | 382 | 0.140 |
Why?
|
| Blood Cells | 1 | 2017 | 309 | 0.130 |
Why?
|
| Stress, Physiological | 2 | 2019 | 1403 | 0.120 |
Why?
|
| High-Throughput Screening Assays | 1 | 2020 | 944 | 0.120 |
Why?
|
| Animals, Genetically Modified | 1 | 2019 | 1549 | 0.120 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2017 | 428 | 0.110 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2022 | 2110 | 0.110 |
Why?
|
| Insect Proteins | 1 | 2014 | 258 | 0.110 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2022 | 2938 | 0.100 |
Why?
|
| Substance P | 2 | 2010 | 335 | 0.100 |
Why?
|
| Cell Line, Tumor | 4 | 2022 | 16692 | 0.100 |
Why?
|
| Bone Marrow Cells | 1 | 2019 | 2513 | 0.100 |
Why?
|
| Pseudomonas putida | 1 | 2011 | 46 | 0.100 |
Why?
|
| Hydro-Lyases | 1 | 2011 | 94 | 0.100 |
Why?
|
| Proteostasis Deficiencies | 1 | 2010 | 38 | 0.090 |
Why?
|
| Nitrogen Isotopes | 1 | 2010 | 84 | 0.090 |
Why?
|
| Carbon Isotopes | 1 | 2010 | 467 | 0.090 |
Why?
|
| Amyotrophic Lateral Sclerosis | 2 | 2010 | 1414 | 0.090 |
Why?
|
| Cattle | 3 | 2010 | 3922 | 0.080 |
Why?
|
| Thyroglobulin | 1 | 2008 | 114 | 0.080 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2019 | 1636 | 0.080 |
Why?
|
| Horses | 1 | 2008 | 304 | 0.080 |
Why?
|
| Solvents | 1 | 2008 | 302 | 0.080 |
Why?
|
| Zebrafish | 1 | 2019 | 2996 | 0.080 |
Why?
|
| Databases, Protein | 1 | 2008 | 383 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2022 | 5535 | 0.070 |
Why?
|
| Antigens, Neoplasm | 1 | 2013 | 1988 | 0.060 |
Why?
|
| Algorithms | 3 | 2010 | 13882 | 0.060 |
Why?
|
| Animals | 8 | 2022 | 168770 | 0.050 |
Why?
|
| Pancreatic Neoplasms | 1 | 2019 | 5263 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 8432 | 0.050 |
Why?
|
| Leukapheresis | 1 | 2020 | 131 | 0.050 |
Why?
|
| Receptor, Nerve Growth Factor | 1 | 2019 | 48 | 0.040 |
Why?
|
| Isotopes | 2 | 2010 | 124 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 11525 | 0.040 |
Why?
|
| 5'-Nucleotidase | 1 | 2019 | 160 | 0.040 |
Why?
|
| Neoplasms | 2 | 2017 | 21693 | 0.040 |
Why?
|
| Atlases as Topic | 1 | 2019 | 236 | 0.040 |
Why?
|
| Receptors, Leptin | 1 | 2019 | 361 | 0.040 |
Why?
|
| K562 Cells | 1 | 2019 | 635 | 0.040 |
Why?
|
| Automation, Laboratory | 1 | 2017 | 101 | 0.040 |
Why?
|
| Phthalazines | 1 | 2019 | 363 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2008 | 13814 | 0.040 |
Why?
|
| Humans | 14 | 2022 | 744376 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2010 | 6194 | 0.030 |
Why?
|
| Cytoprotection | 1 | 2017 | 210 | 0.030 |
Why?
|
| Software | 1 | 2010 | 4442 | 0.030 |
Why?
|
| Models, Molecular | 3 | 2011 | 5451 | 0.030 |
Why?
|
| Stem Cell Niche | 1 | 2019 | 346 | 0.030 |
Why?
|
| Molecular Sequence Data | 1 | 2008 | 18111 | 0.030 |
Why?
|
| Centrifugation | 1 | 2015 | 122 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2019 | 1341 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2019 | 2086 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 1 | 2019 | 874 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2019 | 1879 | 0.030 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2019 | 713 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2019 | 1284 | 0.030 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2017 | 504 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2009 | 6542 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2019 | 2717 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 14723 | 0.030 |
Why?
|
| Male | 6 | 2022 | 350118 | 0.030 |
Why?
|
| Cell Shape | 1 | 2013 | 375 | 0.030 |
Why?
|
| Binding Sites | 2 | 2011 | 6111 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 3556 | 0.020 |
Why?
|
| Cell Size | 1 | 2013 | 643 | 0.020 |
Why?
|
| Transfection | 1 | 2019 | 5895 | 0.020 |
Why?
|
| Histidine | 1 | 2011 | 313 | 0.020 |
Why?
|
| RNA, Neoplasm | 1 | 2013 | 769 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2019 | 4208 | 0.020 |
Why?
|
| Hematopoiesis | 1 | 2019 | 2073 | 0.020 |
Why?
|
| Epitope Mapping | 1 | 2010 | 311 | 0.020 |
Why?
|
| Catalysis | 1 | 2011 | 762 | 0.020 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2010 | 349 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2017 | 2076 | 0.020 |
Why?
|
| Mutation | 2 | 2010 | 29786 | 0.020 |
Why?
|
| Cyclotrons | 1 | 2008 | 30 | 0.020 |
Why?
|
| Antioxidants | 1 | 2017 | 1659 | 0.020 |
Why?
|
| Static Electricity | 1 | 2009 | 263 | 0.020 |
Why?
|
| Aspartic Acid | 1 | 2011 | 576 | 0.020 |
Why?
|
| Piperazines | 1 | 2019 | 2488 | 0.020 |
Why?
|
| Homeostasis | 1 | 2019 | 3339 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2011 | 1247 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2011 | 1723 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2017 | 4222 | 0.020 |
Why?
|
| Mice | 3 | 2019 | 81202 | 0.020 |
Why?
|
| Protein Folding | 1 | 2010 | 840 | 0.020 |
Why?
|
| Cell Survival | 1 | 2017 | 5882 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2010 | 2012 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 2011 | 1169 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2010 | 2184 | 0.020 |
Why?
|
| Insulin | 2 | 2010 | 6582 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2015 | 5974 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2019 | 14561 | 0.010 |
Why?
|
| Molecular Structure | 1 | 2008 | 1899 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2019 | 10484 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2019 | 19233 | 0.010 |
Why?
|
| Kinetics | 1 | 2011 | 6476 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2009 | 4010 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2019 | 5445 | 0.010 |
Why?
|
| Female | 5 | 2019 | 380200 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2010 | 6621 | 0.010 |
Why?
|
| Apoptosis | 1 | 2017 | 9726 | 0.010 |
Why?
|
| Computational Biology | 1 | 2010 | 3519 | 0.010 |
Why?
|
| Protein Binding | 1 | 2009 | 9384 | 0.010 |
Why?
|
| Peptides | 1 | 2008 | 4410 | 0.010 |
Why?
|
| Aged | 1 | 2010 | 163284 | 0.000 |
Why?
|
| Middle Aged | 1 | 2010 | 213388 | 0.000 |
Why?
|
| Adult | 1 | 2010 | 214056 | 0.000 |
Why?
|